|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||

*
Department of Medicine, Division of Pulmonary and Critical Care Medicine, University of Michigan Medical School, Ann Arbor, MI 48109; and
Department of Microbiology, Toho University, Tokyo, Japan
Sepsis syndrome is frequently complicated by the development of
nosocomial infections, particularly Gram-negative pneumonia. Although
TNF-
(TNF) has been shown to mediate many of the pathophysiologic
events in sepsis, this cytokine is a critical component of innate
immune response within the lung. Therefore, we hypothesized that the
transient transgenic expression of TNF within the lung during the
postseptic period could augment host immunity against nosocomial
pathogens. To test this, mice underwent 26-gauge cecal ligation and
puncture (CLP) as a model of abdominal sepsis, followed 24 h later
by intratracheal (i.t.) administration of Pseudomonas
aeruginosa. In animals undergoing sham surgery followed by
bacterial challenge, Pseudomonas were nearly completely
cleared from the lungs by 24 h. In contrast, mice undergoing CLP
were unable to clear P. aeruginosa and rapidly developed
bacteremia. Alveolar macrophages (AM) recovered from mice 24 h
after CLP produced significantly less TNF ex vivo, as compared with AM
from sham animals. Furthermore, the adenoviral mediated transgenic
expression of TNF within the lung increased survival in CLP animals
challenged with Pseudomonas from 25% in animals
receiving control vector to 91% in animals administered recombinant
murine TNF adenoviral vector. Improved survival in recombinant murine
TNF adenoviral vector-treated mice was associated with enhanced lung
bacterial clearance and proinflammatory cytokine expression, as well as
enhanced AM phagocytic activity and cytokine expression when cultured
ex vivo. These observations suggest that intrapulmonary
immunostimulation with TNF can reverse sepsis-induced impairment in
antibacterial host defense.
This article has been cited by other articles:
![]() |
C. E. O. Baleeiro, P. J. Christensen, S. B. Morris, M. P. Mendez, S. E. Wilcoxen, and R. Paine III GM-CSF and the impaired pulmonary innate immune response following hyperoxic stress Am J Physiol Lung Cell Mol Physiol, December 1, 2006; 291(6): L1246 - L1255. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. T. Sadikot, H. Zeng, M. Joo, M. B. Everhart, T. P. Sherrill, B. Li, D.-s. Cheng, F. E. Yull, J. W. Christman, and T. S. Blackwell Targeted Immunomodulation of the NF-{kappa}B Pathway in Airway Epithelium Impacts Host Defense against Pseudomonas aeruginosa. J. Immunol., April 15, 2006; 176(8): 4923 - 4930. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. K. Varma, M. Durham, E. D. Murphey, W. Cui, Z. Huang, C. Y. Lin, T. Toliver-Kinsky, and E. R. Sherwood Endotoxin Priming Improves Clearance of Pseudomonas aeruginosa in Wild-Type and Interleukin-10 Knockout Mice Infect. Immun., November 1, 2005; 73(11): 7340 - 7347. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Sterns, N. Pollak, B. Echtenacher, and D. N. Mannel Divergence of Protection Induced by Bacterial Products and Sepsis-Induced Immune Suppression Infect. Immun., August 1, 2005; 73(8): 4905 - 4912. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. T. Sadikot, T. S. Blackwell, J. W. Christman, and A. S. Prince Pathogen-Host Interactions in Pseudomonas aeruginosa Pneumonia Am. J. Respir. Crit. Care Med., June 1, 2005; 171(11): 1209 - 1223. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Moriyama, A. Ishizaka, M. Nakamura, H. Kubo, T. Kotani, S. Yamamoto, E. N. Ogawa, O. Kajikawa, C. W. Frevert, Y. Kotake, et al. Enhancement of the endotoxin recognition pathway by ventilation with a large tidal volume in rabbits Am J Physiol Lung Cell Mol Physiol, June 1, 2004; 286(6): L1114 - L1121. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. T. Sadikot, H. Zeng, F. E. Yull, B. Li, D.-s. Cheng, D. S. Kernodle, E. D. Jansen, C. H. Contag, B. H. Segal, S. M. Holland, et al. p47phox Deficiency Impairs NF-{kappa}B Activation and Host Defense in Pseudomonas Pneumonia J. Immunol., February 1, 2004; 172(3): 1801 - 1808. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. I. Ojielo, K. Cooke, P. Mancuso, T. J. Standiford, K. M. Olkiewicz, S. Clouthier, L. Corrion, M. N. Ballinger, G. B. Toews, R. Paine III, et al. Defective Phagocytosis and Clearance of Pseudomonas aeruginosa in the Lung Following Bone Marrow Transplantation J. Immunol., October 15, 2003; 171(8): 4416 - 4424. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. E. O. Baleeiro, S. E. Wilcoxen, S. B. Morris, T. J. Standiford, and R. Paine III Sublethal Hyperoxia Impairs Pulmonary Innate Immunity J. Immunol., July 15, 2003; 171(2): 955 - 963. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-M. Sallenave, G. A. Cunningham, R. M. James, G. McLachlan, and C. Haslett Regulation of Pulmonary and Systemic Bacterial Lipopolysaccharide Responses in Transgenic Mice Expressing Human Elafin Infect. Immun., July 1, 2003; 71(7): 3766 - 3774. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Nakamura, Y. Mori, K. Hagiwara, T. Suzuki, T. Sakakibara, T. Kikuchi, T. Igarashi, M. Ebina, T. Abe, J. Miyazaki, et al. Increased Susceptibility to LPS-induced Endotoxin Shock in Secretory Leukoprotease Inhibitor (SLPI)-deficient Mice J. Exp. Med., March 3, 2003; 197(5): 669 - 674. [Abstract] [Full Text] [PDF] |
||||
![]() |
S B Gordon and R C Read Macrophage defences against respiratory tract infections: The immunology of childhood respiratory infections Br. Med. Bull., March 1, 2002; 61(1): 45 - 61. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Wu, S. Hussain, Y.-H. He, R. Pasula, P. A. Smith, and W. J. Martin II Genetically engineered macrophages expressing IFN-gamma restore alveolar immune function in scid mice PNAS, November 20, 2001; (2001) 251451498. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. J. Simpson, W. A. H. Wallace, M. E. Marsden, J. R. W. Govan, D. J. Porteous, C. Haslett, and J.-M. Sallenave Adenoviral Augmentation of Elafin Protects the Lung Against Acute Injury Mediated by Activated Neutrophils and Bacterial Infection J. Immunol., August 1, 2001; 167(3): 1778 - 1786. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Wu, S. Hussain, Y.-H. He, R. Pasula, P. A. Smith, and W. J. Martin II Genetically engineered macrophages expressing IFN-gamma restore alveolar immune function in scid mice PNAS, December 4, 2001; 98(25): 14589 - 14594. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |